Cumberland Pharmaceuticals Inc. (CPIX) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.13HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
LENZ
LENZ Therapeutics, Inc.
$3.75HealthcareDelayed quote: Oct 6, 2026, 10:15 AM EDT
Total return — CPIX vs LENZ
growth of $100 · dividends reinvested · last 5yCPIX +172.1% (+22.2%/yr)LENZ -91.4% (-38.7%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX LENZ
CPIX vs LENZ: by the numbers
- •LENZ is the larger company ($117M vs $107M market cap).
- •Both run net losses; CPIX's is the smaller (-33.92% vs -586.74% net margin).
- •CPIX pays a dividend (21.16% yield), while LENZ is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | CPIX | LENZ |
|---|---|---|
| P/S ratio | 3.42 | 5.47 |
| P/B ratio | 6.13 | 0.54 |
Profitability
| Metric | CPIX | LENZ |
|---|---|---|
| Gross margin | 83.37% | 90.14% |
| Operating margin | -6.27% | -477.46% |
| Net margin | -33.92% | -586.74% |
| ROE | -60.82% | -57.47% |
| ROIC | -34.77% | -61.84% |
Dividends
| Metric | CPIX | LENZ |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | LENZ |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | N/A |
| Total return CAGR (5Y) | 25.62% | -35.49% |
Frequently asked
- Does CPIX or LENZ pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while LENZ is a former payer with no current dividend run rate.
- How have CPIX and LENZ total returns compared?
- Over the past 5 years, CPIX delivered 25.62% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROELENZ Therapeutics ROECumberland Pharmaceuticals operating marginLENZ Therapeutics operating marginCumberland Pharmaceuticals revenue growthLENZ Therapeutics revenue growthCumberland Pharmaceuticals free cash flowLENZ Therapeutics free cash flow
Cumberland Pharmaceuticals & LENZ Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.